Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1420-1424

  Winski, Shannon L ^a   Koutalos, Yiannis ^b   Bentley, David L ^c   Ross, David ^a  

^a Departments of Pharmaceutical Sciences   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; HT29 CELLS; HUMANS; LUNG NEOPLASMS; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASMS;

EID: 0036494316     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DT-diaphorase
2. Quinone reductases
3. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems
4. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function
5. The reduction of α-tocopherolquinone by human NAD(P)H: Quinone oxidoreductase: The role of α-tocopherolhydroquinone as a cellular antioxidant
6. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C
7. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies
8. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
9. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H: Quinone oxidoreductase 1
10. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C->T mutation and rapid fractional excretion of chlorzoxazone
11. Prevalence of the inactivating 609C->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia
12. Low NAD(P)H. Quinone oxidoreductase I activity is associated with increased risk of acute leukemia in adults
13. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
14. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin
15. Cytosolic NAD(P)H. (quinone-acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol
16. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin Cl
17. Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity
18. Electron microscopy and EM immunocytochemistry
19. Ernster relation to respiratory chain of intact mitochondria
20. Distribution of newly synthesized DT-diaphorase in rat liver
21. Levels and subcellular distributions of detoxifying enzymes in the ovarian corpus luteum of the pregnant and nonpregnant pig
22. Activity and immunohistochemistry of DT-diaphorase in hamster and human kidney tumours
23. Nucleocytoplasmic protein transport and recycling of Ran
24. Intranuclear targeted delivery of functional NF-κB by 70 kDa heat shock protein
25. Heat-shock protein 70 can replace viral protein R of HIV-I during nuclear import of the viral preintegration complex
26. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
27. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines
28. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones